Anti-human ERBB1 / EGFR / HER1 (Shanghai Cancer Inst patent Anti-EGFRvIII Biosimilar)

Anti-human ERBB1 / EGFR / HER1 (Shanghai Cancer Inst patent Anti-EGFRvIII Biosimilar)